Dr. Allen Lichter Joins Cellworks Group Board of Directors
Former CEO of ASCO Elected to Board of Leading Precision Medicine Company
SAN…
Tackling the TB epidemic
LONDON—As tuberculosis drug sensitivity and resistance reaches epidemic proportions in many…
Wellcome Trust supports collaboration to find new treatment for tuberculosis
The Wellcome Trust has supported a collaboration between AstraZeneca and Cellworks to speed the…
AstraZeneca And Cellworks Collaborate To Find New Treatment For Tuberculosis
AstraZeneca and Cellworks today announced a collaboration supported by the Wellcome Trust to…
Predicting Pathway Effects
Drug development programs today have a 5% to 10% probability of success. Almost half of the…
Innovate while derisking drug development- yes we can!
The outlook for the drug industry continues to remain bleak in context of productivity and…
Cellworks Taps Semiconductor Expertise to Boost Predictability
With $7.5 million of Series A funding in hand and a Series B round on deck, Cellworks Group Inc…
Going for multiple shots on goal
As the first part of this series began with the single word, "Viagra," this installment begins…
